Form 8-K - Current report:
SEC Accession No. 0001728117-25-000037
Filing Date
2025-05-15
Accepted
2025-05-15 16:02:16
Documents
15
Period of Report
2025-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K goss-20250515.htm   iXBRL 8-K 31997
2 EX-99.1 goss-20250515xexx991.htm EX-99.1 72534
6 GRAPHIC newgosslogoa.jpg GRAPHIC 3033
  Complete submission text file 0001728117-25-000037.txt   242392

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20250515.xsd EX-101.SCH 1794
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20250515_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20250515_pre.xml EX-101.PRE 12516
17 EXTRACTED XBRL INSTANCE DOCUMENT goss-20250515_htm.xml XML 2724
Mailing Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121 (858) 684-1300
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

EIN.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 25952450
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)